Pulmonary embolism: incidence and outcomes in a twelve-year historical series, in Tuscany - Italy (2010-2021).

Pulmonary embolism; Incidence trends; Epidemiological analysis; Mortality determinants; Anticoagulant Drugs; Gender Differences

Journal

Annali di igiene : medicina preventiva e di comunita
ISSN: 1120-9135
Titre abrégé: Ann Ig
Pays: Italy
ID NLM: 9002865

Informations de publication

Date de publication:
24 Jul 2024
Historique:
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 25 7 2024
Statut: aheadofprint

Résumé

Pulmonary embolism poses a global health concern. Administrative databases serve as valuable sources for broad epidemiological studies on the prevalence and incidence of major diagnoses or diseases. The primary scope is to provide up-to-date insights into Pulmonary Embolism incidence trends, examining shifts in management and outcomes. This retrospective observational study examines a 12-year dataset from hospitals in the Tuscany Region, covering the first two years of the Covid-19 pandemic. Administrative data from residents aged 18 and older discharged from hospital between 2010 and 2021 were used for the analysis. Hospitalized pulmonary embolism incidence slightly declined from 2010 to 2019 (64.7 to 60.9 x 100,000; p=0.152). Males under 75 showed a higher incidence rate, while females had higher incidence rates in older age groups. In-hospital and 30-day mortality decreased from 2010 to 2019 (p=0.001 and 0.020 respectively). In 2020, 30-day mortality increased (12.4% vs 10.1%, p=0.029), while in-hospital mortality remained stable. One-year mortality was stable from 2010-2019 but increased in 2020 (32.6% vs 29.4%, p=0.037). Considering the multivariable model, one-year mortality is significantly associated with sex, age, and comorbidities. Our study shows that Pulmonary Embolism persists as a relevant burden in Tuscany region, but with improvements in management over the past decade and a decisive change in pharmacological treatment. Gender-related differences emerge, highlighting the need for a gender-specific healthcare approach.

Sections du résumé

Background UNASSIGNED
Pulmonary embolism poses a global health concern. Administrative databases serve as valuable sources for broad epidemiological studies on the prevalence and incidence of major diagnoses or diseases. The primary scope is to provide up-to-date insights into Pulmonary Embolism incidence trends, examining shifts in management and outcomes.
Design UNASSIGNED
This retrospective observational study examines a 12-year dataset from hospitals in the Tuscany Region, covering the first two years of the Covid-19 pandemic.
Methods UNASSIGNED
Administrative data from residents aged 18 and older discharged from hospital between 2010 and 2021 were used for the analysis.
Results UNASSIGNED
Hospitalized pulmonary embolism incidence slightly declined from 2010 to 2019 (64.7 to 60.9 x 100,000; p=0.152). Males under 75 showed a higher incidence rate, while females had higher incidence rates in older age groups. In-hospital and 30-day mortality decreased from 2010 to 2019 (p=0.001 and 0.020 respectively). In 2020, 30-day mortality increased (12.4% vs 10.1%, p=0.029), while in-hospital mortality remained stable. One-year mortality was stable from 2010-2019 but increased in 2020 (32.6% vs 29.4%, p=0.037). Considering the multivariable model, one-year mortality is significantly associated with sex, age, and comorbidities.
Conclusions UNASSIGNED
Our study shows that Pulmonary Embolism persists as a relevant burden in Tuscany region, but with improvements in management over the past decade and a decisive change in pharmacological treatment. Gender-related differences emerge, highlighting the need for a gender-specific healthcare approach.

Identifiants

pubmed: 39049525
doi: 10.7416/ai.2024.2649
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Gabriele Cerini (G)

Post-graduate School of Hygiene and Preventive Medicine, University of Florence, Italy.

Carla Lunetta (C)

Post-graduate School of Hygiene and Preventive Medicine, University of Florence, Italy.

Claudia Szasz (C)

Regional Health Agency of Tuscany, Florence, Italy.

Leonardo Misuraca (L)

Invasive Cardiology, Azienda USL Toscana Centro, San Giuseppe Hospital, Empoli (Florence), Italy.

Fabrizio Gemmi (F)

Regional Health Agency of Tuscany, Florence, Italy.

Marisa Carluccio (M)

Second Division of Cardiology, Pisa University Hospital, Pisa, Italy.

Chiara Lorini (C)

Department of Health Sciences, University of Florence, Italy.

Guglielmo Bonaccorsi (G)

Department of Health Sciences, University of Florence, Italy.

Silvia Forni (S)

Regional Health Agency of Tuscany, Florence, Italy.

Classifications MeSH